NDRG1 and CRK-I/II are regulators of endothelial cell migration under intermittent hypoxia

Angiogenesis

Volumn 12, Issue 4, 2009, Pages 339-354

  Toffoli, Sébastien ^a   Delaive, Edouard ^a   Dieu, Marc ^a   Feron, Olivier ^b   Raes, Martine ^a   Michiels, Carine ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Cell migration; CRK; Endothelial cells; Intermittent hypoxia; NDRG1

Indexed keywords

CELL PROTEIN; GLUCOSE REGULATED PROTEIN 78; PROTEIN CRK I; PROTEIN CRK II; PROTEIN NDRG1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL HYPOXIA; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

CELL CYCLE PROTEINS; CELL HYPOXIA; CELL LINE, TRANSFORMED; CELL MOVEMENT; DRUG ADMINISTRATION SCHEDULE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; HYBRID CELLS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MASS SPECTROMETRY; OXYGEN; POLYMERASE CHAIN REACTION; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-CRK; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 71249096888     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-009-9156-2     Document Type: Article

References (40)

1. S Toffoli C Michiels 2008 Intermittent hypoxia is a key regulator of cancer cell, endothelial cell interplay in tumours Febs J 275 2991 3002 10.1111/j.1742-4658.2008.06454.x 1:CAS:528:DC%2BD1cXnsVart7s%3D 18445039 (Pubitemid 351743577)
2. MW Dewhirst 2007 Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting Cancer Res 67 854 855 10.1158/0008-5472. CAN-06-4744 1:CAS:528:DC%2BD2sXht1ynt7c%3D 17283112 (Pubitemid 46270735)
3. H Yamaura T Matsuzawa 1979 Tumor regrowth after irradiation; an experimental approach Int J Radiat Biol Relat Stud Phys Chem Med 35 201 219 10.1080/09553007914550241 1:STN:280:DyaE1M3hsFCqsA%3D%3D 222702
4. P Martinive F Defresne C Bouzin J Saliez F Lair V Gregoire C Michiels C Dessy O Feron 2006 Preconditioning of the tumor vasculature, tumor cells by intermittent hypoxia: implications for anticancer therapies Cancer Res 66 11736 11744 10.1158/0008-5472.CAN-06-2056 1:CAS:528:DC%2BD28Xhtlagu7%2FM 17178869 (Pubitemid 46094185)
5. RA Cairns T Kalliomaki RP Hill 2001 Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors Cancer Res 61 8903 8908 1:CAS:528:DC%2BD38Xht1OltA%3D%3D 11751415
6. Toffoli S, Roegiers A, Feron O, Van Steenbrugge M, Ninane N, Raes M, Michiels C (2009) Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1. Angiogenesis 12:47-67
7. J Nanduri G Yuan GK Kumar GL Semenza NR Prabhakar 2008 Transcriptional responses to intermittent hypoxia Respir Physiol Neurobiol 164 277 281 10.1016/j.resp.2008.07.006 1:CAS:528:DC%2BD1cXht1Kntb%2FE 18692603
8. WM Freeman SE Hemby 2004 Proteomics for protein expression profiling in neuroscience Neurochem Res 29 1065 1081 10.1023/B:NERE.0000023594.21352.17 1:CAS:528:DC%2BD2cXjtVWmu7c%3D 15176464 (Pubitemid 39023482)
9. CJ Edgell CC McDonald JB Graham 1983 Permanent cell line expressing human factor VIII-related antigen established by hybridization Proc Natl Acad Sci USA 80 3734 3737 10.1073/pnas.80.12.3734 1:STN:280:DyaL3s3itFKksw%3D%3D 6407019
10. P Martinive F Defresne E Quaghebeur G Daneau N Crokart V Gregoire B Gallez C Dessy O Feron 2009 Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells-new insights for anti-tumor treatments Febs J 276 509 518 10.1111/j.1742-4658.2008.06798.x 1:CAS:528:DC%2BD1MXptV2lug%3D%3D 19077164
11. A Endo S Fukuhara M Masuda T Ohmori N Mochizuki 2003 Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF J Recept Signal Transduct Res 23 239 254 10.1081/RRS-120025567 1:CAS:528: DC%2BD3sXps1egsLs%3D 14626450 (Pubitemid 37362243)
12. A Salameh F Galvagni M Bardelli F Bussolino S Oliviero 2005 Direct recruitment of CRK, GRB2 to VEGFR-3 induces proliferation, migration, survival of endothelial cells through the activation of ERK, AKT, JNK pathways Blood 106 3423 3431 10.1182/blood-2005-04-1388 1:CAS:528:DC%2BD2MXht1ehsb%2FL 16076871 (Pubitemid 41609177)
13. KV Stoletov C Gong BI Terman 2004 Nck and Crk mediate distinct VEGF-induced signaling pathways that serve overlapping functions in focal adhesion turnover, integrin activation Exp Cell Res 295 258 268 10.1016/j.yexcr.2004.01.008 1:CAS:528:DC%2BD2cXis1Wgs70%3D 15051508 (Pubitemid 38410661)
14. G Hopfl O Ogunshola M Gassmann 2004 HIFs tumors-causes, consequences Am J Physiol Regul Integr Comp Physiol 286 R608 R623 15003941
15. MC Brahimi-Horn J Chiche J Pouyssegur 2007 Hypoxia signalling controls metabolic demand Curr Opin Cell Biol 19 223 229 10.1016/j.ceb.2007.02.003 1:CAS:528:DC%2BD2sXjt1Sksro%3D 17303407 (Pubitemid 46386401)
16. MC Brahimi-Horn J Pouyssegur 2007 Hypoxia in cancer cell metabolism, pH regulation Essays Biochem 43 165 178 10.1042/BSE0430165 1:CAS:528: DC%2BD2sXhtFGqtbfP 17705800
17. S Toffoli O Feron M Raes C Michiels 2007 Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha Biochim Biophys Acta 1773 1558 1571 10.1016/j.bbamcr.2007.06.002 1:CAS:528:DC%2BD2sXhtFehsrvI 17662481 (Pubitemid 47498610)
18. RJ Zeleznikar RA Heyman RM Graeff TF Walseth SM Dawis EA Butz ND Goldberg 1990 Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle J Biol Chem 265 300 311 1:CAS:528:DyaK3cXlt1ygug%3D%3D 2152922
19. E Miclet V Stoven PA Michels FR Opperdoes JY Lallemand F Duffieux 2001 NMR spectroscopic analysis of the first two steps of the pentose-phosphate pathway elucidates the role of 6-phosphogluconolactonase J Biol Chem 276 34840 34846 10.1074/jbc.M105174200 1:CAS:528:DC%2BD3MXmvFCluro%3D 11457850
20. RA Jones P Kotsakis TS Johnson DY Chau S Ali G Melino M Griffin 2006 Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth Cell Death Differ 13 1442 1453 10.1038/sj.cdd.4401816 1:CAS:528:DC%2BD28XotVyltrg%3D 16294209 (Pubitemid 44210348)
21. TP Ellen Q Ke P Zhang M Costa 2008 NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states Carcinogenesis 29 2 8 10.1093/carcin/bgm200 1:CAS:528:DC%2BD1cXhs1aitr0%3D 17916902 (Pubitemid 351201735)
22. H Cangul 2004 Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers BMC Genet 5 27 10.1186/1471-2156-5-27 15341671 (Pubitemid 41363876)
23. H Cangul K Salnikow H Yee D Zagzag T Commes M Costa 2002 Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells Environ Health Perspect 110 Suppl 5 783 788 1:CAS:528:DC%2BD38XovFKhsb8%3D 12429530
24. J Akiba S Ogasawara A Kawahara N Nishida S Sanada F Moriya M Kuwano O Nakashima H Yano 2008 N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma Oncol Rep 20 1329 1335 19020710
25. MS Chua H Sun ST Cheung V Mason J Higgins DT Ross ST Fan S So 2007 Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma Mod Pathol 20 76 83 10.1038/modpathol.3800711 1:CAS:528: DC%2BD28XhtlaktrnK 17170744 (Pubitemid 44967952)
26. Z Wang F Wang WQ Wang Q Gao WL Wei Y Yang GY Wang 2004 Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm World J Gastroenterol 10 550 554 1:CAS:528: DC%2BD2cXislalurw%3D 14966915
27. MA Shah N Kemeny A Hummer M Drobnjak M Motwani C Cordon-Cardo M Gonen GK Schwartz 2005 Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes Clin Cancer Res 11 3296 3302 10.1158/1078-0432.CCR-04-2417 1:CAS:528:DC%2BD2MXjslOqtr8%3D 15867226 (Pubitemid 40627878)
28. Y Maruyama M Ono A Kawahara T Yokoyama Y Basaki M Kage S Aoyagi H Kinoshita M Kuwano 2006 Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis Cancer Res 66 6233 6242 10.1158/0008-5472.CAN-06-0183 1:CAS:528:DC%2BD28XlvVSkt7s%3D 16778198
29. KL Agarwala K Kokame H Kato T Miyata 2000 Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein Biochem Biophys Res Commun 272 641 647 10.1006/bbrc.2000.2833 1:CAS:528:DC%2BD3cXktVKksLc%3D 10860807 (Pubitemid 30420691)
30. T Sugiki M Murakami Y Taketomi R Kikuchi-Yanoshita I Kudo 2004 N-myc downregulated gene 1 is a phosphorylated protein in mast cells Biol Pharm Bull 27 624 627 10.1248/bpb.27.624 1:CAS:528:DC%2BD2cXksVylu74%3D 15133234 (Pubitemid 41694660)
31. S Domhan S Muschal C Schwager C Morath U Wirkner W Ansorge C Maercker M Zeier PE Huber A Abdollahi 2008 Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid Mol Cancer Ther 7 1656 1668 10.1158/1535-7163.MCT-08-0193 1:CAS:528:DC%2BD1cXnsVSkur4%3D 18566237
32. LC Tu X Yan L Hood B Lin 2007 Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells Mol Cell Proteomics 6 575 588 10.1074/mcp.M600249-MCP200 1:CAS:528:DC%2BD2sXksVKgtb0%3D 17220478 (Pubitemid 46630091)
33. L Lamorte S Rodrigues M Naujokas M Park 2002 Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic program J Biol Chem 277 37904 37911 10.1074/jbc.M201743200 1:CAS:528:DC%2BD38XnsVejtLY%3D 12138161
34. SP Rodrigues KE Fathers G Chan D Zuo F Halwani S Meterissian M Park 2005 CrkI and CrkII function as key signalling integrators for migration and invasion of cancer cells Mol Cancer Res 3 183 194 1:CAS:528:DC%2BD2MXjt1Wmt7w%3D 15831672
35. SM Feller 2001 Crk family adaptors-signalling complex formation and biological roles Oncogene 20 6348 6371 10.1038/sj.onc.1204779 1:CAS:528:DC%2BD3MXnvVegsL0%3D 11607838 (Pubitemid 32977844)
36. M Matsuda S Tanaka S Nagata A Kojima T Kurata M Shibuya 1992 Two species of human CRK cDNA encode proteins with distinct biological activities Mol Cell Biol 12 3482 3489 1:CAS:528:DyaK3sXkt1Gmtb4%3D 1630456
37. RL Klemke J Leng R Molander PC Brooks K Vuori DA Cheresh 1998 CAS/Crk coupling serves as a "molecular switch" for induction of cell migration J Cell Biol 140 961 972 10.1083/jcb.140.4.961 1:CAS:528: DyaK1cXhtlegtbg%3D 9472046 (Pubitemid 28141232)
38. N Uemura JD Griffin 1999 The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration J Biol Chem 274 37525 37532 10.1074/jbc.274.53.37525 1:CAS:528:DC%2BD3cXkt1GjsA%3D%3D 10608804 (Pubitemid 30026805)
39. M Tsuda Y Makino T Iwahara H Nishihara H Sawa K Nagashima H Hanafusa S Tanaka 2004 Crk associates with ERM proteins and promotes cell motility toward hyaluronic acid J Biol Chem 279 46843 46850 10.1074/jbc.M401476200 1:CAS:528:DC%2BD2cXptFejsrw%3D 15326184 (Pubitemid 39518335)
40. H Yano H Uchida T Iwasaki M Mukai H Akedo K Nakamura S Hashimoto H Sabe 2000 Paxillin alpha and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation Proc Natl Acad Sci USA 97 9076 9081 10.1073/pnas.97.16.9076 1:CAS:528: DC%2BD3cXls12ksrs%3D 10922062 (Pubitemid 30626676)